Focusing on CRO & CMO Industry Upgrading, Helping Enterprises Seize New Industry Opportunities

With the big rise of innovative drugs, the global pharmaceutical expenditures continue to grow, and the CRO & CMO industry enters the new stage of rapid development, wherein, the emerging CRO & CMO market in Asia-Pacific region is now in the golden period of development, leading the world with the compound annual growth rate of over 20%.

Under this background, the ICSE China 2019 will take place again in Hall E2/E7 of Shanghai New International Expo Centre on June 18-20, 2019. Well-known Chinese and overseas exhibitors and pharmaceutical industry experts will gather at the show, centrally showcase advanced products and technologies in the pharma CRO & CMO area, and jointly explore opportunities and challenges of the industry in the future.

To integrate with other exhibitions and create an annual gala of pharmaceutical R&D

ICSE China will be held concurrently with CPhI China 2019, bioLIVE China 2019, and other co-located exhibitions, and the event will attract over 70,000 visits of professional visitors in the pharmaceutical field from 120 countries and regions, gather over 3,200 leading pharmaceutical enterprises to exhibit, and link upstream and downstream enterprises in the pharmaceutical industry to jointly create a legend event of the year for the pharmaceutical industry.

Exhibition scale to be fully upgraded; 90% stands of ICSE China 2019 already booked

ICSE China is becoming a first choice for CROs & CMOs to publicize brands and expand markets, by virtue of the platform advantages of high level of internationalization and full coverage of the pharmaceutical industry. Over 90% stands have been booked by the middle of December 2018. Well-known Chinese and overseas CROs and CMOs such as Porton, Asymchem, LinkChem, PharmaBlock, Sphinx, ABA, Sundia, and Chemspec have confirmed their continued exhibition, and will display their latest technologies and relevant services in the environment full of new opportunities, including pharmaceutical custom synthesis, biotech clinical research, medicinal chemistry, and registration and regulation, etc.

To focus on the pharmaceutical R&D, and present splendid content events on site

ICSE China 2019 will continue with the "exhibition" and "conference" combination mode, join hands with professional institutions and industry media to hold the pharmaceutical R&D summit, to focus on hot topics of the CRO & CMO industry, trace closely the international frontier situation, and establish an information exchange platform integrating trade, networking, and knowledge acquisition for the insiders.

ICSE China 2019

June 18-20 2019, SNIEC, Shanghai, China

Organizer：UBM EMEA, CCCMHPIE

Co-organizer：UBM Sinoexpo

Contact detail:

Ms. Yingqi Shi

E: yingqi.shi@ubmsinoexpo.com

T: +86 21-33392421

Website:

http://www.cphi-china.cn/icse/en